Presentations and Publications

The presentations and publications contained in this archive section are provided for historical purposes only. The information contained in each presentation or publication is accurate only as of the date it was originally issued. Ra Pharmaceuticals disavows any obligation to update the information contained in such presentations and publications after the date of their issuance.

Latest Investor Presentation


2019 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting


Ra Pharmaceuticals 2019 Analyst and Investor Breakfast Presentation (June 18, 2019)


2019 American Academy of Neurology Annual Meeting

Zilucoplan, a Subcutaneously Self-Administered Peptide Inhibitor of Complement Component 5 (C5), for the Treatment of Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial and Open-Label Long-Term Extension


6th Annual Peptides Congress


Conference Call on Zilucoplan Top-line Phase 2 gMG Data (December 10, 2018)


2018 European Hematology Association Annual Meeting


2017 European Hematology Association Annual Meeting


International PNH Interest Group 11th Annual Scientific Meeting


2016 European Hematology Association Annual Meeting


2015 American Society of Hematology Annual Meeting